NCT03433001 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- groups
- description
- Participants took ixazomib, lenalidomide, and dexamethasone under conditions of standard medical care in this study. The dosage and administration of ixazomib, lenalidomide, and dexamethasone were not defined by the protocol but according to the package insert of each drug.
- id
- BG000
- title
- Ixazomib + Lenalidomide + Dexamethasone
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.62
- value
- 71.9
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 127
- title
- Female
- measurements
- group Id
- BG000
- value
- 168
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- denoms
- counts
- group Id
- BG000
- value
- 0
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Race and Ethnicity were not collected from any participant.
- title
- Race and Ethnicity Not Collected
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 295
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Japan
- description
- All participants were enrolled in Japan.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.70
- value
- 157.2
- denoms
- counts
- group Id
- BG000
- value
- 288
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- Hight
- unit Of Measure
- Centimeters (cm)
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.122
- value
- 56.91
- denoms
- counts
- group Id
- BG000
- value
- 277
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- Weight
- unit Of Measure
- Kilograms (kg)
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 3.353
- value
- 22.96
- denoms
- counts
- group Id
- BG000
- value
- 276
- units
- Participants
- description
- Body Mass Index = weight (kg)/\[height (m)\^2\]
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- BMI
- unit Of Measure
- Kilogram (kg)/meter (m)^2]
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.1830
- value
- 1.562
- denoms
- counts
- group Id
- BG000
- value
- 276
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- Body Surface Area
- unit Of Measure
- m^2
- classes
- categories
- measurements
- group Id
- BG000
- value
- 78
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Stage I
- categories
- measurements
- group Id
- BG000
- value
- 112
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Stage II
- categories
- measurements
- group Id
- BG000
- value
- 101
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Stage III
- categories
- measurements
- group Id
- BG000
- value
- 4
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Missing
- description
- International Staging System is a staging system for cancer progression. Stages are classified by Stage I to Stage III. Stage I: Serum beta2-microglobulin \<3.5 mg/L and albumin ≥3.5 g/dL; Stage II: Neither Stage I or III, meaning that either: beta2-microglobulin level ≥3.5 and \<5.5 mg/L (with any albumin level), OR albumin \<3.5 g/dL with beta2-microglobulin \<3.5 mg/L; Stage III: Serum beta2-microglobulin ≥5.5 mg/L. Normal serum beta2-microglobulin: \<3.0 mg/L; normal albumin: 3.5-5.0 g/dL.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- International Staging System (at Initial Diagnosis)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 130
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Stage I
- categories
- measurements
- group Id
- BG000
- value
- 78
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Stage II
- categories
- measurements
- group Id
- BG000
- value
- 31
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Stage III
- categories
- measurements
- group Id
- BG000
- value
- 56
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- International Staging System (at First Treatment)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 147
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 90
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 23
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 18
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- 3
- categories
- measurements
- group Id
- BG000
- value
- 5
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- 4
- categories
- measurements
- group Id
- BG000
- value
- 12
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Missing
- description
- ECOG P.S. assess participant's performance status on 5 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory ( greater than \[\>\] 50 percent \[%\] of waking hours), capable of all self-care, unable to carry out any work activities; 3=capable of only limited self-care, confined to bed/chair \>50% of waking hours; 4=completely disabled, cannot carry on any self-care, totally confined to bed/chair; 5=dead.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group performance status (ECOG P.S.)
- unit Of Measure
- Participants
- population Description
- Full Analysis Set, defined as all participants who were enrolled into the study and who receive at least one dose of ixazomib.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- groups
- description
- Participants took ixazomib, lenalidomide, and dexamethasone under conditions of standard medical care in this study. The dosage and administration of ixazomib, lenalidomide, and dexamethasone were not defined by the protocol but according to the package insert of each drug.
- id
- BG000
- title
- Ixazomib + Lenalidomide + Dexamethasone
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.62
- value
- 71.9
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 127
- title
- Female
- measurements
- group Id
- BG000
- value
- 168
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- denoms
- counts
- group Id
- BG000
- value
- 0
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Race and Ethnicity were not collected from any participant.
- title
- Race and Ethnicity Not Collected
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 295
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Japan
- description
- All participants were enrolled in Japan.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.70
- value
- 157.2
- denoms
- counts
- group Id
- BG000
- value
- 288
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- Hight
- unit Of Measure
- Centimeters (cm)
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.122
- value
- 56.91
- denoms
- counts
- group Id
- BG000
- value
- 277
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- Weight
- unit Of Measure
- Kilograms (kg)
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 3.353
- value
- 22.96
- denoms
- counts
- group Id
- BG000
- value
- 276
- units
- Participants
- description
- Body Mass Index = weight (kg)/\[height (m)\^2\]
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- BMI
- unit Of Measure
- Kilogram (kg)/meter (m)^2]
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.1830
- value
- 1.562
- denoms
- counts
- group Id
- BG000
- value
- 276
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- The number analyzed is the number of participants with data available for analysis.
- title
- Body Surface Area
- unit Of Measure
- m^2
- classes
- categories
- measurements
- group Id
- BG000
- value
- 78
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Stage I
- categories
- measurements
- group Id
- BG000
- value
- 112
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Stage II
- categories
- measurements
- group Id
- BG000
- value
- 101
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Stage III
- categories
- measurements
- group Id
- BG000
- value
- 4
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Missing
- description
- International Staging System is a staging system for cancer progression. Stages are classified by Stage I to Stage III. Stage I: Serum beta2-microglobulin \<3.5 mg/L and albumin ≥3.5 g/dL; Stage II: Neither Stage I or III, meaning that either: beta2-microglobulin level ≥3.5 and \<5.5 mg/L (with any albumin level), OR albumin \<3.5 g/dL with beta2-microglobulin \<3.5 mg/L; Stage III: Serum beta2-microglobulin ≥5.5 mg/L. Normal serum beta2-microglobulin: \<3.0 mg/L; normal albumin: 3.5-5.0 g/dL.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- International Staging System (at Initial Diagnosis)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 130
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Stage I
- categories
- measurements
- group Id
- BG000
- value
- 78
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Stage II
- categories
- measurements
- group Id
- BG000
- value
- 31
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Stage III
- categories
- measurements
- group Id
- BG000
- value
- 56
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- International Staging System (at First Treatment)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 147
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 90
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 23
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 18
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- 3
- categories
- measurements
- group Id
- BG000
- value
- 5
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- 4
- categories
- measurements
- group Id
- BG000
- value
- 12
- denoms
- counts
- group Id
- BG000
- value
- 295
- units
- Participants
- title
- Missing
- description
- ECOG P.S. assess participant's performance status on 5 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory ( greater than \[\>\] 50 percent \[%\] of waking hours), capable of all self-care, unable to carry out any work activities; 3=capable of only limited self-care, confined to bed/chair \>50% of waking hours; 4=completely disabled, cannot carry on any self-care, totally confined to bed/chair; 5=dead.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group performance status (ECOG P.S.)
- unit Of Measure
- Participants
- population Description
- Full Analysis Set, defined as all participants who were enrolled into the study and who receive at least one dose of ixazomib.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle